文献速递瓣膜病与结构性心脏病血脂与心血管预防

二尖瓣置换或修复与感染性心内膜炎长期风险:丹麦全国性研究

Mitral valve replacement or repair and long-term risk of infective endocarditis: a Danish nationwide study.
PubMed 文献 · Eur Heart J · 2025-01-01

结果显示二尖瓣置换10年累积发生率为6.1%,修复为1.6%,中危组为1.7%;多变量调整后置换与较高感染性心内膜炎风险相关(HR 3.52),修复无显著关联(HR 0.76)。

要点

  • 二尖瓣置换后10年感染性心内膜炎累积发生率为6.1%,显著高于中危人群的1.7%。
  • 二尖瓣修复后10年感染性心内膜炎累积发生率为1.6%,与中危人群无显著差异。
  • 多变量调整后,置换与感染性心内膜炎风险增加3.52倍相关,修复无显著关联。

核心结论

  • 与感染性心内膜炎中危患者相比,二尖瓣置换与10年感染性心内膜炎发生率增加3.5倍相关,而二尖瓣修复无显著关联。
  • 研究结果提示需进一步探究预防措施,包括靶向抗生素预防。

研究设计与样本

  • 基于丹麦全国登记数据库(2000-2020年)的全国性队列研究。
  • 研究人群包括接受孤立二尖瓣置换或修复的患者,以及感染性心内膜炎中危患者。
  • 中危组包括心脏植入式电子设备、先天性心脏瓣膜异常、肥厚型心肌病、风湿性心脏病和非风湿性退行性瓣膜病。
  • 采用Aalen-Johansen估计量和病因特异性Cox回归模型比较10年感染性心内膜炎发生率。

主要发现

  • 二尖瓣置换的10年累积感染性心内膜炎发生率为6.1%(95%CI 4.8%-7.7%)。
  • 二尖瓣修复的10年累积感染性心内膜炎发生率为1.6%(95%CI 1.1%-2.1%)。
  • 中危组的10年累积感染性心内膜炎发生率为1.7%(95%CI 1.6%-1.7%)。
  • 多变量调整后,与中危组相比,二尖瓣置换与较高的10年感染性心内膜炎发生率相关(HR 3.52,95%CI 2.73-4.52),而二尖瓣修复无显著关联(HR 0.76,95%CI 0.56-1.04)。

临床怎么用

  • 对于接受二尖瓣置换的患者,应关注其长期感染性心内膜炎风险,并考虑进一步研究预防措施。
  • 二尖瓣修复患者的感染性心内膜炎风险与中危人群相当,可能无需额外的靶向预防。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Infective endocarditis (IE) after mitral valve (MV) interventions is a serious complication. However, information on the long-term risk of first-time IE after MV replacement or repair is lacking. The 10-year incidence of first-time IE was examined in patients undergoing MV replacement or repair, compared with those at moderate risk of IE. METHODS: Using Danish nationwide registries (2000-2020), the study population included patients undergoing isolated MV replacement or repair and patients at moderate risk of IE. The moderate-risk group included cardiac implantable electronic devices, congenital heart valve anomalies, hypertrophic cardiomyopathy, rheumatic heart diseases, and non-rheumatic degenerative valve diseases. The Aalen-Johansen estimator and cause-specific Cox regression models were used to determine the 10-year comparative incidences of IE. RESULTS: The study population included 1220 patients undergoing MV replacement, 3239 undergoing MV repair, and 209 517 at moderate risk of IE. The 10-year cumulative incidences of IE were 6.1% [95% confidence interval (CI) 4.8%-7.7%] for MV replacement, 1.6% (95% CI 1.1%-2.1%) for MV repair, and 1.7% (95% CI 1.6%-1.7%) for the moderate-risk group. Compared with the moderate-risk group, after multivariable adjustment, MV replacement was associated with a higher 10-year IE rate (hazard ratio 3.52, 95% CI 2.73-4.52), whereas MV repair was not associated with IE (hazard ratio 0.76, 95% CI 0.56-1.04). CONCLUSIONS: In this nationwide study, MV replacement was associated with a 3.5-fold increased 10-year IE rate, whereas MV repair was not significantly associated with IE, compared with patients at moderate risk of IE. These findings highlight the need for further investigation into preventive measures, including targeted antibiotic prophylaxis.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Alhakak A, Butt JH, Havers-Borgersen E, et al. Mitral valve replacement or repair and long-term risk of infective endocarditis: a Danish nationwide study. Eur Heart J. 2025. PMID: 40641372. doi:10.1093/eurheartj/ehaf342

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。